Home/Filings/4/0001127602-24-014850
4//SEC Filing

Bradner James E. 4

Accession 0001127602-24-014850

CIK 0000318154other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 6:59 PM ET

Size

8.1 KB

Accession

0001127602-24-014850

Insider Transaction Report

Form 4
Period: 2024-05-07
Bradner James E.
EVP, R&D, & Chief Sci. Officer
Transactions
  • Award

    Common Stock

    2024-05-07+2,86325,438 total
  • Award

    Nqso (Right to Buy)

    2024-05-07$300.30/sh+18,603$5,586,48118,603 total
    Exercise: $300.30From: 2026-05-07Exp: 2034-05-07Common Stock (18,603 underlying)
Footnotes (4)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
  • [F2]These shares include the following RSUs granted under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan: 8,587 RSUs which will vest in installments of 2,833 on 2/9/2026, 2,834 on 2/9/2027, and 2,920 on 2/9/2028; 13,806 RSUs which will vest in installments of 4,555 on 2/9/2026, 4,556 on 2/9/2027, and 4,695 on 2/9/2028; and 2,863 RSUs which will vest in installments of 944 on 5/7/2026, 945 on 5/7/2027, and 974 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 182 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0002005159

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:59 PM ET
Size
8.1 KB